symbol

Novartis Venture Funds hopes to invest in Israel in 2013

An $800 million budget has made Novartis Venture Funds the largest fund of a pharmaceutical company and positions the fund as one of the biggest funds in the pharmaceutical and medical devices industry. When venture capital investment in Israel’s life sciences is limited, it is encouraging to know that Novartis Venture Funds managing director Florent Gros visited Israel a few weeks ago to attend the Go4Europe conference of Catalyst Investments LP and Cuckierman & Co. Investment House Ltd.

You can read more here